About the Authors
- Kenneth W. Foreman
-
Contributed equally to this work with: Kenneth W. Foreman, Mark Brown, Philip Tucker
* E-mail: kforeman@coferon.com
Current address: Coferon Inc., New York, New York, United States of America
Affiliation OSI Pharmaceuticals, Inc., Farmingdale, New York, United States of America
- Mark Brown
-
Contributed equally to this work with: Kenneth W. Foreman, Mark Brown, Philip Tucker
Current address: Colorado State University, Fort Collins, Colorado, United States of America
Affiliation University of Texas, Institute for Cellular and Molecular Biology, Austin, Texas, United States of America
- Frances Park
-
Affiliation AltheaDx, Inc., San Diego, California, United States of America
- Spencer Emtage
-
Affiliation Eli Lilly and Company, San Diego, California, United States of America
- June Harriss
-
Affiliation University of Texas, Institute for Cellular and Molecular Biology, Austin, Texas, United States of America
- Chhaya Das
-
Affiliation University of Texas, Institute for Cellular and Molecular Biology, Austin, Texas, United States of America
- Li Zhu
-
Affiliation University of Texas, Institute for Cellular and Molecular Biology, Austin, Texas, United States of America
- Andy Crew
-
Affiliation OSI Pharmaceuticals, Inc., Farmingdale, New York, United States of America
- Lee Arnold
-
Affiliation DiscoverElucidations, LLC. Mt. Sinai, New York, United States of America
- Salam Shaaban
-
Affiliation Abbott Bioresearch Center, Worcester, Massachusetts, United States of America
- Philip Tucker
-
Contributed equally to this work with: Kenneth W. Foreman, Mark Brown, Philip Tucker
Affiliation University of Texas, Institute for Cellular and Molecular Biology, Austin, Texas, United States of America
Competing Interests
KF, AC, LA, and SS were employed by OSI Pharmaceuticals at the time of the contribution and are currently employed at Coferon, Inc.; employed at OSI Pharmaceuticals, a wholly owned subsidiary of Astellas Pharma; self-employed (DiscoverElucidations); and employed at Abbott, respectively. FP and SE were employed at SGX Pharmaceuticals at the time of the contribution and are currently employed at AltheaDx and Eli Lilly, respectively. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: KWF FP SE AC LA SS PT. Performed the experiments: KWF MB JH CD LZ. Analyzed the data: KWF SS PT. Wrote the paper: KWF MB SS PT.